EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 19 filers reported holding EFFECTOR THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 2.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $615,316 | -27.7% | 1,025,697 | 0.0% | 1.38% | -4.7% |
| Q2 2023 | $851,534 | +135.4% | 1,025,697 | 0.0% | 1.45% | +101.1% |
| Q1 2023 | $361,763 | -17.5% | 1,025,697 | 0.0% | 0.72% | +0.8% |
| Q4 2022 | $438,588 | -25.3% | 1,025,697 | 0.0% | 0.72% | -21.7% |
| Q3 2022 | $587,000 | -59.7% | 1,025,697 | 0.0% | 0.91% | -54.4% |
| Q2 2022 | $1,456,000 | -64.6% | 1,025,697 | 0.0% | 2.00% | -36.0% |
| Q1 2022 | $4,113,000 | -51.6% | 1,025,697 | 0.0% | 3.13% | -18.2% |
| Q4 2021 | $8,493,000 | – | 1,025,697 | – | 3.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTORAL ASSET MANAGEMENT INC | 2,382,644 | $1,113,648 | 0.48% |
| Oasis Management Co Ltd. | 100,000 | $1,168,000 | 0.22% |
| Carlyle Group Inc. | 4,822,114 | $2,228,781 | 0.11% |
| Alyeska Investment Group, L.P. | 364,934 | $4,264,254 | 0.03% |
| Parallel Advisors, LLC | 1,693,559 | $791,569 | 0.02% |
| Sonora Investment Management Group, LLC | 125,000 | $58,425 | 0.01% |
| Blackstone Inc. | 1,308,587 | $611,634 | 0.00% |
| Wescott Financial Advisory Group, LLC | 30,556 | $14,282 | 0.00% |
| Callan Capital, LLC | 20,000 | $9,348 | 0.00% |
| SIMPLEX TRADING, LLC | 1,735 | $0 | 0.00% |